Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Thoracic Society, U.S.
For idiopathic pulmonary fibrosis patients, a simple walk test predicts mortality rates
October 13th, 2006
A new study of individuals with idiopathic pulmonary fibrosis (IPF) patients awaiting lung transplantation has found that those who can cover less than 680 feet during a six-minute walk test are four times more likely to die than those who can walk greater distances. The research appears in the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society. David J. Lederer, MD, of the Division of Pulmonary, Allergy and Critical Care Medicine at Columbia University College of Physicians and Surgeons in New York City, and five associates examined the records of 454 adult IPF patients on U.S....
Source: Medicine & Law Weekly (2006-10-13)
|
